2022
DOI: 10.1093/ndt/gfab339
|View full text |Cite
|
Sign up to set email alerts
|

Erratum to: Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 0 publications
0
12
0
Order By: Relevance
“…Sleep disturbances and/or depression are frequent in patients with CKD. Both of these conditions have negative effects on cognitive performance [44]. Sleep-disordered breathing, commonly known as sleep apnea, is widely prevalent among individuals with CKD and has been observed to impact cognitive testing in CKD patients, leading to detrimental effects on cognitive functioning [45,46].…”
Section: Sleep Disturbances and Depressionmentioning
confidence: 99%
See 1 more Smart Citation
“…Sleep disturbances and/or depression are frequent in patients with CKD. Both of these conditions have negative effects on cognitive performance [44]. Sleep-disordered breathing, commonly known as sleep apnea, is widely prevalent among individuals with CKD and has been observed to impact cognitive testing in CKD patients, leading to detrimental effects on cognitive functioning [45,46].…”
Section: Sleep Disturbances and Depressionmentioning
confidence: 99%
“…An RCT is currently looking at whether intradialytic combined cognitive and exercise training can efficaciously preserve cognitive health [90]. One can assume that stimulation of this type improves cognitive performance by reducing depressive symptoms and improving quality of life [44].…”
Section: Introductionmentioning
confidence: 99%
“…Data on the prevalence of CI in kidney transplant recipients are limited, different criteria to assess cognitive function are used between studies, and there are no formally validated screening tests for kidney transplant recipients [12]. It is known that patients and their caregivers can potentially benefit from CI screening, such as education and support for patients and their caregivers, modification of pharmacotherapy, or identification of potentially reversible causes of dementia, such as depression, side effects of drugs, drug, or alcohol abuse [13]. Furthermore, depression and/or anxiety may coexist with any stage of CKD and may affect cognitive test results [14].…”
Section: Introductionmentioning
confidence: 99%
“…There is increased awareness of the need for more patient‐centred approaches for the management of the substantial burden of physical and psychological symptoms that are not adequately addressed by usual treatment strategies (Kalantar‐Zadeh et al., 2022). In addition to dialysis therapy and pharmacotherapies targeting underlying diseases and complications linked to CKD, strategies based on a holistic perspective—involving nonpharmacological interdisciplinary interventions aiming at increasing physical activity and improving the nutritional, cognitive and emotional state of the patients may provide additional benefits including enhancing the HRQoL of patients and their carers (Kalantar‐Zadeh et al., 2021; Pépin et al., 2021). Before recommending general application of these types of interventions, which are currently scarce, it is important to analyse patients' own perceptions of their needs, barriers and facilitators associated with self‐implementation of these promoters of health (Lunney et al., 2018; Tam‐Tham et al., 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Patients with advanced stages of chronic kidney disease (CKD) often suffer from comorbidities such as cardiovascular, cerebrovascular and peripheral vascular diseases, and diabetes that together with malnutrition and frailty contribute to a sedentary lifestyle, cognitive and emotional impairments (Pépin et al., 2021), increased dependency, and decreased health‐related quality of life (HRQoL) (Chan, 2021; Charles & Ferris, 2020; Harnett et al., 2018; Ortega‐Pérez de Villar et al., 2020; Schouten et al., 2020; Shoji et al., 2022). These problems remain despite the large societal and healthcare costs of CKD stages 4 and 5, not least for those undergoing dialysis (Kalantar‐Zadeh et al., 2021; Pépin et al., 2021).…”
Section: Introductionmentioning
confidence: 99%